GLP-1(7-36)amide is an insulinotropic peptide derived from the intesti
nal post-translational proglucagon process, the release of which is in
creased mainly after a carbohydrate meal; also, its anti-diabetogenic
effect in normal and diabetic states has been reported. In this study,
GLP-1(7-36)amide stimulates the formation of glycogen from glucose in
isolated rat hepatocytes, such a glycogenic effect being achieved wit
h physiological concentrations of the peptide. The GLP-1(7-36)amide-in
duced glycogenesis is abolished by glucagon, and it is accompanied by
stimulation of the glycogen synthase a activity and by a decrease in t
he basal and glucagon-stimulated cyclic AMP content. These findings co
uld explain, at least in part, the GLP-1(7-36)amide insulin-independen
t plasma glucose lowering effect.